---
layout: post
title: "Methodological Challenges Related to Patient Experience Data; Request for Information and Comments"
date: 2026-02-05 18:55:24 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2023-09265
original_published: 2023-05-02 00:00:00 +0000
significance: 8.00
---

# Methodological Challenges Related to Patient Experience Data; Request for Information and Comments

**Published:** February 05, 2026 18:55 UTC
**Source:** Federal Register
**Original Published:** May 02, 2023 00:00 UTC
**Document Number:** 2023-09265

## Summary

The Food and Drug Administration (FDA or Agency) is establishing a public docket to collect comments on methodological challenges related to patient experience data in the context of the benefit-risk assessment and product labeling, and other areas of greatest interest or concern to public stakeholders. Public comments will help FDA plan two public workshops focused on methodological challenges and identify priorities for future work.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2023/05/02/2023-09265/methodological-challenges-related-to-patient-experience-data-request-for-information-and-comments)
- API: https://www.federalregister.gov/api/v1/documents/2023-09265

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
